Tratamientos psicológicos eficaces para el trastorno obsesivo compulsivo

Referencias bibliográficas

• Abramowitz, J.S. (1998). Does cognitive-behavioral therapy cure obsessive-compulsive disorder? A meta-analytic evaluation of clinical significance. Behavior Therapy, 29, 339-355.
• Abramowitz, J.S., Franklin, M.E., Street, G.P., Kozak, M.J. y Foa (2000). Effects of pretreatment depression on treatment outcome in OCD. Behavior Therapy, en prensa.
• Ananth, J., Pecknold, J.C., van der Steen, N. y Engelsmann, F. (1981). Double blind comparative study of clomipramina and amitriptiline in obsessive neurosis. Progressive Neuropsychopharmacology, 5, 257-262.
• Aubuchon, P.G. y Malatesta, V.J. (1994). Obsessive compulsive patients with comorbid personality disorder: associated problems and response to a comprehensive behavior therapy. Journal of Clinical Psychiatry, 55, 448-453.
• Bachofen, M., Nakagawa, A., Marks, I.M., Park, J.M., Greist; J.H., Baer, L., Wenzel, K.W., Parkin, J.R. y Dottl, S.L. (1999). Home self-assessment and self-treatment of obsessive-compulsive disorder using a manual and a computer-conduced telephone interview: replication of a UK-US study. Journal of Clinical Psychiatry, 60, 545-549.
• Baer, L., Jenike, M.A., Black, D.W., Treece, C., Rosenfeld, R. y Greist, J. (1992). Effect of axis II diagnoses on treatment outcome with clomipramine in 55 patients with obsessive-compulsive disorder. Archives of General Psychiatry, 49, 862-866.
• Barr, L.C., Goodman, W.K., Price, L.H., McDougle, C.J. y Charney, D.S. (1992). The serotonin hypothesis of obsessive compulsive disorder: Implications of pharmacologic challenge studies. Journal of Clinical Psychiatry, 53(Suppl. 4), 17-28.
• Beck, A. (1976). Cognitive therapy and the emotional disorders. Nueva York: International Universities Press.
• Beech, H.R. y Vaughn, M. (1978). Behavioral treatment of obsessional states. Nueva York: Wiley.
• Boersma, K., Den Hengst, S., Dekker, J. y Emmelkamp, P.M.G. (1976). Exposure and response prevention: A comparison with obsessive compulsive patients. Behaviour Research and Therapy, 14, 19-24.
• Bolton, D., Raven, P., Madronal-Luque, R. y Marks, I.M. (2000). Neurological and neuropsychological signs in obsessive compulsive disorder: interaction with behavioural treatment. Behaviour Research and Therapy, 38, 695-708.
• Calvocoressi, L., Lewis, B., Harris, M., Trufan, S., Goodman, W., McDougle, C. y Proce, L. (1995). Family accommodations in obsessive-compulsive disorder. American Journal of Psychiatry, 152, 441-443.
• Clark, D. y Purdon, C. (1993). New perspectives for a cognitive theory of depression. Australian Psychologist, 28, 161-167.
• Clomipramine Collaborative Group (1991). Clomipramine in the treatment of patient with obsessive-compulsive disorder. Archives of General Psychiatry, 48, 730-738.
• Coryel, W. (1981). Obsessive-compulsive disorder and primary unipolar depression. Journal of Nervous and Mental Disease, 169, 220-224.
• Cottraux, J. (2000). Cognitive therapy and behavioural therapy in obsessive-compulsive disorder: in search of the process. En M. Maj, N. Sartorius, A. Okasha y J. Zohar (eds.), Obsessive-compulsive disorder (pp. 129-131). Nueva York: Wiley.
• Cottraux, J., Mollard, E., Bouvard, M., Marks, I., Sluys, M., Nury, A.M., Douge, R. y Cialdella, P. (1990). A controlled study of fluvoxamine and exposure in obsessive compulsive-disorder. International Clinical Psychopharmacology, 5, 17-30.
• Cottraux, J., Mollard, E., Bouvard, M. y Marks, I. (1993). Exposure therapy, flovoxamine, or combination treatment in obsessive-compulsive disorder: one year follow up. Psychiatry Research, 49, 63-75.
• de Araujo, L.A., Ito, L.M., Marks, I.M. y Deale, A. (1995). Does imagined exposure to the consequences of not ritualizing enhance live exposure for OCD? A controlled study. I. Main outcome. British Journal of Psychiatry, 167, 65-70.
• Den Boer, J .A., Westenberg, H.G.M., Kamerbeek, W., Verhoeven, W.M. y Kahn, R.S. (1987). Effect of serotonin uptake inhibitors in anxiety disorders: A double-blind comparison of c lomipramine and fluvoxamine. International Clinical Psychopharmacology, 2, 21-32.
• Dollar, J. y Miller, N.E. (1950). Personality and psychotherapy: An analysis in terms of learning, thinking and culture. Nueva York: McGrawHill.
• Emmelkamp, P.M.G. y Beens, H. (1991). Cognitive therapy with obsessive-compulsive disorder: A comparative evaluation. Behaviour Research and Therapy, 29, 293-300.
• Emmelkamp, P.M.G., de Haan, E. y Hooggduin, C.A.L. (1990). Marital adjustment and obsessive-compulsive disorder. British Journal of Psychiatry, 156, 55-60.
• Emmelkamp, P.M.G., van der Helm, M., van Zanten, B.L. y Plochg, I. (1980). Treatment of obsessive-compulsive patients: The contribution of self-instructions training to the effectiveness of exposure. Behaviour Research and Therapy, 18, 61-66.
• Emmelkamp, P.M.G., Visser, S. y Hoekstra, R.J. (1988). Cognitive therapy versus exposure in vivo in the treatment of obsessive-compulsives. Cognitive Therapy and Research, 12, 103-114.
• Fals-Stewart, W. y Lucente, S. (1993). An MCMI cluster typology of obsessive-compulsives: a measure of personality characteristics and its relationship to treatment participation, compliance and outcome in behavior therapy. Journal of Psychiatry Research, 27, 139-154.
• Fals-Stewart, W., Marks, A.P. y Schafer, J. (1993). A comparison of behavioral group therapy and individual behavior therapy in treating obsessive-compulsive disorder. Journal of Nervous and Mental Disease, 181, 189-193.
• Fernández-Córdoba, E. y López-Ibor Aliño, J. (1967). Monochlorimipramina in mental patients resisting other forms of treatment. Actas LusoEspañolas de Neurología y Psiquiatría, 26, 119-147.
• Foa, E.B. y Goldstein, A. (1978). Continuous exposure and complete response prevention in the treatment of obsessive-compulsive neurosis. Behavior Therapy, 9, 821-829.
• Foa, E.B., Grayson, J.B., Steketee, G.S., Doppelt, H.G., Turner, R.M. y Latimer, P.R. (1983). Success and failure in the behavioral treatment of obsessive-compulsive. Journal of Consulting and Clinical Psychology, 51, 287-297.
• Foa, E.B., Kozak, M.J., Goodman. W.K., Hollander, E., Jenike, M. y Ramussen, S. (1995). DSM-IV field trial: Obsessive-compulsive disorder. American Journal of Psychiatry, 152, 90-94.
• Foa, E.B. y Steketee, G.S. (1979). Obsessive-compulsives: Conceptual issues and treatment interventions. En M. Hersen, R.M. Eisler y P.M. Miller (eds.), Progress in behavior modification. Vol. 8. Nueva York: Academic Press.
• Foa, E.B., Steketee, G.S. y Grayson, J.B. (1985). Imaginal and in vivo exposure: A comparison with obsessive-compulsive checkers. Behavior Therapy, 16, 292-302.
• Foa, E.B., Steketee, G., Grayson, J.B., Turner, R.M. y Latimer, P. (1984). Deliberate exposure and blocking of obsessive-compulsive rituals: Immediate and long term effects. Behavior Therapy, 15, 450-472.
• Foa, E.B., Steketee, G.S. y McCarthy, P.R. (1992). Treatment of depressive and obsessive-compulsive symptoms in OCD by imipramine and behavior therapy. British Journal of Clinical Psychology, 31, 279-292.
• Franklin, M.E., Abramowitz, J.S., Kozak, M.J., Levitt, J. y Foa, E.B. (2000). Effectiveness of exposure and ritual prevention for obsessive-compulsive disorder: randomized compared with nonrandomized samples. Journal of Consulting and Clinical Psychology, 68, 594-602.
• Freeman, C.P.L., Trimble, M.R., Deakin, J.F., Stokes, T.M. y Ashford, J .J. (1994). Fluvoxamine versus clomipramine in the treatment of obsessive compulsive disorder: A multicenter, randomized, double-blind, parallel group comparison. Journal of Clinical Psychiatry, 55, 301-305.
• Greist, J.H. (1989). Computer-administered behavior therapies. International Review of Psychiatry, 1, 267-294.
• Greist, J.H, Chouinard, G., DuBoff, E., Halaris, A., Kim, S.W., Koran, L., Liebowitz, M., Lydiard, R.B., Rasmussen, S. y White, K. (1995a). Double-blind comparison of three doses of sertraline and placebo in the treatment of outpatients with obsessive compulsive disorder. Archives of General Psychiatry, 52, 289-295.
• Greist, J.H., Jefferson, J.W., Kobak, K.A., Katzelnick, D.J., y Serlin, R.C. (1995b). Efficacy and tolerability of serotonin transport inhibitors in obsessive-compulsive disorder: A metaanalysis. Archives of General Psychiatry, 52, 53-60.
• Greist, J.H., Jefferson, J.W., Rosenfeld, R., Gutzman, L.D., March, J.S. y Barklage, N.E. (1990). Clomipramine and obsessive-compulsive disorder: A placebo-controlled double-blind study of 32 patients. Journal of Clinical Psychiatry, 51, 292-297.
• Greist, J.H., Marks, I.M., Baer, L., Parkin, R., Manzo, P., Mantle, J.M., Wenzel, K.W., Spierings, C.J., Koback, K.A. y Dottl, S.L. (1998). Selftreatment for obsessive compulsive disorder using a manual and a computerized telephone interview: a US-UK study. MD Computing, 15, 149-157.
• Hanna, G.L. (1995). Demographics and clinical features of obsessive-compulsive disorder in children and adolescents. Journal of the American Academy of Child and Adolescent Psychiatry, 34, 19-27.
• Hoogduin, C.A.L. y Duivenvoorden, H.J. (1988). A decision model in the treatment of obsessive-compulsive neurosis. British Journal of Psychiatry, 152, 516-521.
• Jenike, M.A., Baer, L., Ballantine, T., Martuza, R., Tynes, S., Girivnas, I., Buttolph, M. y Cassen, N. (1991). Cingulotomy for refractory obsessive-compulsive disorder. Archives of General Psychiatry, 48, 548-555.
• Jenike, M.A., Baer, L. y Carey, R.J. (1986). Coexistence obsessive-compulsive disorder and schizotypical personality disorder: a poor prognostic indicator. Archives of General Psychiatry, 43, 296.
• Jenike, M.A., Hyman, S.E., Baer, L., Holland, S., Baer, L., Holland, A., Minichiello, W.E., Buttolph, L., Summergrad, P., Seymour, R. y Ricciardi, J. (1990). A controlled trial of fluvoxamine for obsessive-compulsive disorder: Implications for a serotoninergic theory. American Journal of Psychiatry, 147, 1209-1215.
• Karno, M. y Golding, J.M. (1991). Obsessive-compulsive disorders. En L.N. Robins y D.A. Regier (eds.), Psychiatric Disorders in America: The Epidemiological Catchment Area Study (pp. 204-219). Nueva York: The Free Press.
• Keijsers, G.P., Hoogduin, C.A., Schaap, C.P. (1994). Predictors of treatment outcome in the behavioural treatment of obsessive-compulsive disorder. British Journal of Psychiatry, 165, 781-786.
• Kirk, J.W. (1983). Behavioural treatment of obsessive compulsive patients in routine clinical practice. Behaviour Research and Therapy, 21, 57-62.
• Kobak, K.A. y Riemann, B.C. (2000). Current issues in the use of behavioural therapy for obsessive-compulsive disorder. En M. Maj, N. Sartorius, A. Okasha y J. Zohar (eds.), Obsessive-compulsive disorder (pp. 134-136). Nueva York: Wiley.
• Kozak, M.J., Liebowitz, M.R. y Foa, E.B. (2000). Cognitive behavior therapy and pharmacotherapy for OCD: The NIMH-sponsored collaborative study. En W. Goodman, M. Rudorfer y J. Maser (eds.), Obsessive compulsive disorder: Contemporary issues in treatment (pp. 501-530). Mahwah: Erlbaum.
• Ladouceur, R., Freeston, M. Gagnon, F., Thibodeau, N. y Dumont, J. (1995). Cognitive behavioral treatment of obsessions and ruminations. Behavior Modification, 19, 247-257.
• Lax, T., Basoglu, M. y Marks, I.M. (1992). Expectancy and compliance as predictors of outcome in obsessive-compulsive disorder. Behavior Psychotherapy, 20, 257-266.
• Lei, B.S. (1986). A cross-over treatment of obsessive compulsive neurosis with imipramine and chlorimipramine. Chung Hua Shen Ching Ko Tsa Chih, 19, 275-278.
• Lindsay, M., Crino, R.y Andrews, G. (1997). Controlled trial of exposure and response prevention in obsessive-compulsive disorder. British Journal of Psychiatry, 171, 135-139.
• Marks, I., Hodgson, R. y Rachman, S. (1975). Treatment of chronic obsessive-compulsive neurosis by in vivo exposure. British Journal of Psychiatry, 127, 349-364.
• Marks, I.M., Stern, R.S., Mawson, D., Cobb, J. y McDonald, R. (1980). Clomipramina and exposure for obsessive-compulsive rituals -I. British Journal of Psychiatry, 136, 1-25.
• Mavissakalian, M., Hamann, M.S. y Jones, B. (1990). DSM-III personality disorders in obsessive-compulsive disorder: changes with treatment. Comprehensive Psychiatry, 31, 432-437.
• Mavissakalian, M., Turner, S.M., Michelson, L. y Jacob, R. (1985). Tricyclic antidepressant in obsessive compulsive disorder: Antiobsessional or antidepressant agents? American Journal of Psychiatry, 142, 572-576.
• Mehta, M. (1990). A comparative study of family-based and patients-based behavioural management in obsessive-compulsive disorder. British Journal of Psychiatry, 157, 133-135.
• Meyer, V. (1966). Modifications of expectations in cases with obsessional rituals. Behaviour Research and Therapy, 4, 273-280.
• Minichiello, W.E., Baer, L. y Jenike, M.A. (1987). Schizotypical personality disorder: a poor prognostic indicator for behavior therapy in the treatment of obsessive compulsive disorder. Journal of Anxiety Disorders, 1, 273-276.
• Mowrer, O.H. (1939). A stimulus-response analysis of anxiety and its role as a reinforcing agent. Psychological Review, 46, 553-565.
• Mowrer, O.H. (1960). Learning theory and behavior. Nueva York: Wiley.
• Myers, J.K., Weisman, M.M., Tischler, G.L., Leaf, P.J., Orvaschel, H., Anthony, J.C. y Boyd, J.H. (1984). Six month prevalence of psychiatric disorders in three sites. Archives of General Psychiatry, 41, 959-971.
• Neziroglu, F., Anemone, R., Yaryura-Tobias, J.A. (1992). Onset of obsessive-compulsive disorder in pregnancy. American Journal of Psychiatry, 149, 947-950.
• O’Connor y Robillard, S. (1995). Inference processes in obsessive-compulsive disorder: Some clinical observations. Behaviour Research and Therapy, 33, 887-896.
• Pigot, T.A., Pato, M.T., Bernstein, S.E., Grover, G.N., Hill, J.L., Tolliver, T.J. y Murphy, D.L. (1990). Controlled comparisons of clomipramine and fluoxetine in the treatment of obsessive-compulsive disorder. Archives of General Psychiatry, 47, 926-932.
• Rabavilas, A.D., Boulougouris, J.C. y Stefanis, C. (1976). Duration of flooding sessions in the treatment of obsessive-compulsive patients. Behaviour Research and Therapy, 14, 349-355.
• Rachman, S. (1998). A cognitive theory of obsessions: elaborations. Behaviour Research and Therapy, 36, 385-401.
• Rachman, S., Cobb, J., Grey, S., McDonald, B., Mawson, D., Sartory, G. y Stern, R. (1979). The behavioural treatment of obsessional-compulsive disorders, with and without clomiparamine. Behaviour Research and Therapy, 17, 467-478.
• Rachman, S. y de Silva, P. (1978). Abnormal and normal obsessions. Behaviour Research and Therapy, 16, 233-248.
• Rasmussen, S.A. y Eisen, J.L. (1989). Clinical features and fenomenology of obsessive compulsive disorders. Psychiatric Annals, 19, 67-73.
• Rasmussen, S.A. y Eisen, J.L. (1990). Epidemiological and clinical features of obsessive-compulsive disorder. En M.A. Jenike, L. Baer y W.E. Minilchiello (eds.), Obsessive-compulsive disorders: theory and management (pp. 10-27). Chicago: Year Book.
• Rasmussen, S., Eisen, J.L. y Pato, M. (1993). Current issues in the pharmacologic management of obsessive compulsive disorder. Journal of Clinical Psychiatry, 54 (Suppl. 6), 4-9.
• Rasmussen, S. y Tsuang, M. (1986). Clinical characteristics and family history in DSM-III obsessive -compulsive disorder. American Journal of Psychiatry, 143, 317-322.
• Rauch, S.L. y Jenike, M.A. (1994). Management of treatment obsessive- compulsive disorder: concepts and strategies. En B. Berend, E. Hollander, D. Marazitti y J. Zohar (eds.), Current insights in obsessive-compulsive disorder (pp. 227-244). Chichester: Wiley.
• Rauch, S.L. y Jenike, M.A. (1998). Pharmacological treatment of obsessive compulsive disorder. En P.E. Nathan y J.M. Gorman (eds.), A guide to treatments that work (pp. 358-376). Nueva York: Oxford Press.
• Robins, L.N., Helzer, J.E., Weisman, M.M., Orvaschel, H., Gruenberg, E., Burke, J .D. y Reiger, D.A. (1984). Lifetime prevalence of specific psychiatric disorders in three sites. Archives of General Psychiatry, 41, 949-959.
• Roper, G., Rachman, S. y Marks, I. (1975). Passive and participant modeling in exposure treatment of obsessive-compulsive neurotics. Behaviour Research and Therapy, 13, 271-279.
• Salkovskis, P.M. (1985). Obsessional and compulsive problems: A cognitive behavioral analysis. Behaviour Research and Therapy, 23, 571- 583.
• Salkovskis, P.M. (1989). Cognitive-behavioral factors and the persistence of intrusive thoughts in obsessional problems. Behaviour Research and Therapy, 27, 677-682.
• Salkovskis, P.M. (1999). Understanding and treating obsessive-compulsive disorder. Behaviour Research and Therapy, 37, S29-S52.
• Salkovskis, P.M. y Harrison, J. (1984). Abnormal and normal obsessions: A replication. Behaviour Research and Therapy, 22, 549-552.
• Silvestre, J. y Aronowitz, B.R. (1997). Behavioral treatment of OCD. En E. Hollander y D.J. Stein (eds.), Obsessive-compulsive disorders (pp. 225-255). Nueva York: Marcel Dekker.
• Steketee, G. y Foa, E.B. (1985). Obsessive-compulsive disorder. En D.H. Barlow (ed.), Psychological treatment of adult disorders: A clinical guide (pp. 68-142). Nueva York: Guilford Press.
• Steketee, G.S. Frost, R.O. (1998). Obsessive-compulsive disorder. En A.S. Bellack y M. Hersen (eds.), Comprehensive Clinical Psychology. Vol. 6 (pp. 367-398). Amsterdam: Pergamon.
• Steketee, G. y Shapiro, L. (1993). Obsessive compulsive disorder. En A.S. Bellack y M. Hersen (eds.), Handbook of behavior therapy in psychiatric setting (pp. 99-127). Nueva York: Plenum.
• Steketee, G. y Shapiro, L.J. (1995). Predicting behavioral treatment outcome for agoraphobia and obsessive compulsive disorder. Clinical Psychology Review, 15, 317-346.
• Stern, R.S. (1978). Obsessive thoughts: the problem of therapy. British Journal of Psychiatry, 133, 200-205.
• Tallis, F., Pratt, P. y Jamani, N. (1999). Obsessive compulsive disorder, checking, and non-verbal memory: a neuropsychological investigation. Behaviour Research and Therapy, 37, 161-166.
• Thoren, P., Asberg, M., Cronholm, B., Jornestedt, L. y Traskman, L. (1980). Clomipramina treatment of obsessive compulsive disorder. I. A controlled trial. Archives of General Psychiatry, 37, 1.281-1.285.
• Tollefson, G.D., Rampey, A.H., Potvin, J.H., Jenike, M.A., Rush, A.J., Domínguez, R.A., Koran, L.M., Shear, M.K., Goodman, W. y Genduso, L.A. (1994). A multicenter investigation of fixed-dose of fluoxetine in the treatment of obsessive-compulsive disorder. Archives of General Psychiatry, 51, 559-567.
• Valleni-Basile, L., Garrison, C., Jackson, K., Waller, J., Makeowa, R., Addy, C. y Cuffe, S. (1994). Frequency of obsessive compulsive disorder in a community sample of young adolescents. Journal of American Academy of Child and Adolescent Psychiatry, 6, 782-791.
• van Balkom, A.J., van Oppen, P, Vermeulen, A., van Dyck, R., Nauta, M.C. y Vorst, H.C. (1994). A meta-analysis on the treatment of obsessive compulsive disorder: a comparison of antidepressants, behavior, and cognitive therapy. Clinical Psychology Review, 5, 359-381.
• van Oppen, P., de Haan, E., van Balkom, A.J., Spinhoven, P., Hoogduin, K. y Van Dyck, R. (1995). Cognitive therapy and exposure in vivo in the treatment of obsessive-compulsive disorder. Behaviour Research and Therapy, 33, 379-390.
• Volavka, J. Neziroglu, F. y Yaryura Tobias, J.A. (1985). Clomipramine and imipramine in obsessive compulsive disorder. Psychiatry Research, 14, 83-91.
• Weismann, M.M., Bland, R.C., Canino; G.J., Greenwald, S. (1994). The Cross National Collaborative Group. The Cross National Epidemiology of Obsessive-Compulsive Disorder. Journal Clinical Psychiatry, 55 (Suplemento 3), 5-10.
• Zhao, J.P. (1991). A controlled study of clomipramine and amitriptyline for treating obsessive-compulsive disorder. Chung Hua Shen Ching Ko Tsa Chic, 24, 68-70.
• Zohar, J., Sasson, Y., Chopra, M., Amital, D. e Iancu, I. (2000). Pharmacological treatment of obsessive-compulsive disorder: a review. En M. Maj, N. Sartorius, A. Okasha y J. Zohar (eds.), Obsessive-compulsive disorder (pp. 43-62). Nueva York: Wiley.